English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 製薬企業関連 > アルツハイマー病治療薬の研究開発企業分析
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

アルツハイマー病治療薬の研究開発企業分析

A Survey of Private Companies Active in Alzheimer's Drug R&D

発行 Startupguys Ltd
出版日 2006年03月 商品コード 37454
ページ情報 英文 148 Pages
価格
US$ 730 換算 ¥ 58,743 (税抜) PDF & Excel File by E-mail (1-5 User License)
US$ 1,090 換算 ¥ 87,712 (税抜) PDF & Excel File by E-mail (Corporate Use License)


原文目次

Abstract

This spin-off report of "A Survey of Private Companies Active in CNS & PNS Drug R&D" comprises the private companies active in Alzheimer's R&D covered in the full report. Launched in March 2006 the product combines an Excel company database covering 86 companies active in Alzheimer's drug research and development with a full cross-referenced report in PDF format describing each company in detail. Contact details, descriptive background information, management team, investors and CNS/PNS drug pipeline are provided for all entries. "A Survey of Private Companies Active in Alzheimer's Drug R&D" is by far the most comprehensive survey of private players active in the Alzheimer's market space available to this date. It is a must have report for everyone professionally involved in Alzheimer's drug development and Alzheimer's drug development companies.

Table of Contents

COMPANY DIRECTORY

  • Ablynx
  • Accera Pharmaceuticals
  • AC Immune
  • Acumen Pharmaceuticals
  • Addex Pharmaceuticals
  • AFFiRiS
  • AGY Therapeutics
  • ArmaGen Technologies
  • Athersys
  • Axon Neuroscience
  • Bicoll
  • Bioarctic Neuroscience
  • Brainsgate
  • Capsant Neurotechnologies
  • Cellzome
  • Cerebricon
  • Ceregene
  • Chiesi Group / Chiesi Farmaceutici
  • CNAssays
  • Cognitive Pharmaceuticals
  • Cognosci
  • CoLucid Pharmaceuticals
  • Daniolabs
  • D-Pharm
  • eNOS Pharmaceuticals
  • EnVivo Pharmaceuticals
  • ESBA Tech
  • Ester Neurosciences
  • Esteve
  • FAN
  • Faust Pharmaceuticals
  • Helicon Therapeutics
  • Howard Associates
  • Hunter-Fleming
  • i3 Research
  • Icogenex
  • Intra-Cellular Therapies
  • Janssen Pharmaceutica (J&J subsidiary)
  • JSW Research
  • KeyNeurotek
  • Kinexis
  • Krenitsky Pharmaceuticals
  • Medexis Biotech (Gerolymatos Subsidiary)
  • Medimod Pharmacology Services
  • MOTAC Neuroscience / MOTAC Cognition
  • Muscagen
  • Neurim Pharmaceuticals
  • Neurobiomed
  • Neurofit
  • Neuroinvestigations
  • Neurology Clinical Research
  • Neurome
  • Neuromolecular Pharmaceuticals
  • Neuronova
  • Neuropharma (Zeltia Subsidiary)
  • Neuroprofile
  • Neurotargets
  • Neurotune
  • Newneural
  • NsGene (Neurosearch Spinoff)
  • Nura
  • Panacea Pharmaceuticals
  • Pharmaxon
  • Pharmidex
  • Predix Pharmaceuticals
  • Priosense
  • Proneuron Biotechnologies
  • ProteoTech
  • Reata Pharmaceuticals
  • reMYND
  • Rinat Neuroscience
  • Rottapharm Group
  • Saegis Pharmaceuticals
  • Senexis
  • Siena Biotech
  • Sigma-Tau Pharmaceuticals / Biofutura Pharma
  • Somerset Pharmaceuticals
  • Targacept
  • The Genetics Company
  • TorreyPines Therapeutics
  • Trophos
  • Ventana CRC
  • Verne Mendel Medical
  • Voyager Pharmaceuticals
  • Zapaq
  • Zyentia
Back to Top